Yellow Card serious ADR — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Submit a Yellow Card report for the suspected serious ADR
This scenario assesses Yellow Card serious ADR in a UK pharmacy practice context. Serious suspected ADRs should be reported even without definitive proof of causality. The best answer is Submit a Yellow Card report for the suspected serious ADR because it addresses the principal clinical, legal or safety issue before routine supply. The other options are less appropriate because they either miss the key risk, delay necessary review, or would not meet expected BNF, NICE, MEP, MHRA or GPhC practice standards.
Reference: MHRA Yellow Card; GPhC Standards